Latent trajectory modelling of pulmonary artery pressure in systemic sclerosis: a retrospective cohort study

被引:1
作者
Kida, Takashi [1 ,2 ]
Matsuzaki, Keiichi [3 ]
Yokota, Isao [4 ]
Kawase, Nozomu [5 ]
Kadoya, Masatoshi [5 ]
Inoue, Hironori [2 ,6 ]
Kukida, Yuji [6 ]
Kaneshita, Shunya [2 ,7 ]
Inoue, Takuya [2 ,7 ]
Wada, Makoto [2 ]
Kohno, Masataka [2 ]
Fukuda, Wataru [5 ]
Kawahito, Yutaka [2 ]
Iwami, Taku [1 ]
机构
[1] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Prevent Serv, Kyoto, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Inflammat & Immunol, Kyoto, Japan
[3] Kyoto Univ, Agcy Hlth Safety & Environm, Kyoto, Japan
[4] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Japan
[5] Japanese Red Cross Kyoto Daiichi Hosp, Ctr Rheumat Dis, Kyoto, Japan
[6] Japanese Red Cross Kyoto Daini Hosp, Dept Rheumatol, Kyoto, Japan
[7] Fukuchiyama City Hosp, Dept Rheumatol, Fukuchiyama, Japan
来源
RMD OPEN | 2022年 / 8卷 / 02期
关键词
Systemic Sclerosis; Cardiovascular Diseases; Epidemiology; Ultrasonography; SYSTOLIC PRESSURE; DISEASE; AUTOANTIBODIES; HYPERTENSION; INVOLVEMENT; PROGRESSION; PREDICTION; PHENOTYPES; MORTALITY; SURVIVAL;
D O I
10.1136/rmdopen-2022-002673
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo visualise the trajectories of pulmonary arterial pressure (PAP) in systemic sclerosis (SSc) and identify the clinical phenotypes for each trajectory, by applying latent trajectory modelling for PAP repeatedly estimated by echocardiography.MethodsThis was a multicentre, retrospective cohort study conducted at four referral hospitals in Kyoto, Japan. Patients with SSc who were treated at study sites between 2008 and 2021 and who had at least three echocardiographic measurements of systolic PAP (sPAP) were included. A group-based trajectory model was applied to the change in sPAP over time, and patients were classified into distinct subgroups that followed similar trajectories. Pulmonary hypertension (PH)-free survival was compared for each trajectory. Multinomial logistic regression analysis was performed for baseline clinical characteristics associated with trajectory assignment.ResultsA total of 236 patients with 1097 sPAP measurements were included. We identified five trajectories: rapid progression (n=9, 3.8%), early elevation (n=30, 12.7%), middle elevation (n=54, 22.9%), late elevation (n=24, 10.2%) and low stable (n=119, 50.4%). The trajectories, in the listed order, showed progressively earlier elevation of sPAP and shorter PH-free survival. In the multinomial logistic regression analysis with the low stable as a reference, cardiac involvement was associated with rapid progression, diffuse cutaneous SSc was associated with early elevation and anti-centromere antibody was associated with middle elevation; older age of onset was associated with all three of these trajectories.ConclusionThe pattern of changes in PAP over time in SSc can be classified into five trajectories with distinctly different clinical characteristics and outcomes.
引用
收藏
页数:7
相关论文
共 27 条
  • [1] All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019
    Bournia, Vasiliki-Kalliopi
    Fragoulis, George E.
    Mitrou, Panagiota
    Mathioudakis, Konstantinos
    Tsolakidis, Anastasios
    Konstantonis, George
    Vourli, Georgia
    Paraskevis, Dimitrios
    Tektonidou, Maria G.
    Sfikakis, Petros P.
    [J]. RMD OPEN, 2021, 7 (03):
  • [2] Systemic sclerosis
    Denton, Christopher P.
    Khanna, Dinesh
    [J]. LANCET, 2017, 390 (10103) : 1685 - 1699
  • [3] Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report
    Elinoff, Jason M.
    Agarwal, Richa
    Barnett, Christopher F.
    Benza, Raymond L.
    Cuttica, Michael J.
    Gharib, Ahmed M.
    Gray, Michael P.
    Hassoun, Paul M.
    Hemnes, Anna R.
    Humbert, Marc
    Kolb, Todd M.
    Lahm, Tim
    Leopold, Jane A.
    Mathai, Stephen C.
    McLaughlin, Vallerie V.
    Preston, Ioana R.
    Rosenzweig, Erika B.
    Shlobin, Oksana A.
    Steen, Virginia D.
    Zamanian, Roham T.
    Solomon, Michael A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (02) : 166 - 174
  • [4] Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
    Fretheim, Havard
    Halse, Anne-Kristine
    Seip, Marit
    Bitter, Helle
    Wallenius, Marianne
    Garen, Torhild
    Salberg, Anne
    Brunborg, Cathrine
    Midtvedt, Oyvind
    Molberg, Oyvind
    Hoffmann-Vold, Anna-Maria
    [J]. RHEUMATOLOGY, 2020, 59 (10) : 2920 - 2929
  • [5] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
    Galie, Nazzareno
    Humbert, Marc
    Vachiery, Jean-Luc
    Gibbs, Simon
    Lang, Irene
    Torbicki, Adam
    Simonneau, Gerald
    Peacock, Andrew
    Noordegraaf, Anton Vonk
    Beghetti, Maurice
    Ghofrani, Ardeschir
    Gomez Sanchez, Miguel Angel
    Hansmann, Georg
    Klepetko, Walter
    Lancellotti, Patrizio
    Matucci, Marco
    McDonagh, Theresa
    Pierard, Luc A.
    Trindade, Pedro T.
    Zompatori, Maurizio
    Hoeper, Marius
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (01) : 67 - +
  • [6] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
    Galie, Nazzareno
    Humbert, Marc
    Vachiery, Jean-Luc
    Gibbs, Simon
    Lang, Irene
    Torbicki, Adam
    Simonneau, Gerald
    Peacock, Andrew
    Noordegraaf, Anton Vonk
    Beghetti, Maurice
    Ghofrani, Ardeschir
    Sanchez, Miguel Angel Gomez
    Hansmann, Georg
    Klepetko, Walter
    Lancellotti, Patrizio
    Matucci, Marco
    McDonagh, Theresa
    Pierard, Luc A.
    Trindade, Pedro T.
    Zompatori, Maurizio
    Hoeper, Marius
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (04) : 903 - 975
  • [7] The Renal Resistive Index: A New Biomarker for the Follow-up of Vascular Modifications in Systemic Sclerosis
    Gigante, Antonietta
    Bruni, Cosimo
    Lepri, Gemma
    Tesei, Giulia
    Maestripieri, Vanessa
    Guiducci, Serena
    Moggi-Pignone, Alberto
    Melchiorre, Daniela
    Boddi, Maria
    Bellando-Randone, Silvia
    Rosato, Edoardo
    Matucci-Cerinic, Marco
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (02) : 241 - 246
  • [8] Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features
    Hoffmann-Vold, Anna-Maria
    Distler, Oliver
    Murray, Baron
    Kowal-Bielecka, Otylia
    Khanna, Dinesh
    Allanore, Yannick
    [J]. RMD OPEN, 2019, 5 (01):
  • [9] The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis
    Kampolis, C.
    Plastiras, S. C.
    Vlachoyiannopoulos, P. G.
    Moyssakis, I.
    Tzelepis, G. E.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 (04) : 278 - 283
  • [10] Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
    Khanna, Dinesh
    Gladue, Heather
    Channick, Richard
    Chung, Lorinda
    Distler, Oliver
    Furst, Daniel E.
    Hachulla, Eric
    Humbert, Marc
    Langleben, David
    Mathai, Stephen C.
    Saggar, Rajeev
    Visovatti, Scott
    Altorok, Nezam
    Townsend, Whitney
    FitzGerald, John
    McLaughlin, Vallerie V.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3194 - 3201